Nasal high-flow therapy as an adjunct to exercise in patients with cystic fibrosis: A pilot feasibility trial

Disease Areas:
Cystic fibrosis
Device Types:
Alpha

This open-label, randomized, pilot crossover trial examined the feasibility of conducting a clinical trial of nasal high-flow therapy as an adjunct to exercise in 23 adult patients with cystic fibrosis and severe lung disease. As part of the study, lung function testing was undertaken 30 minutes before and after a 6MWT using a Vitalograph Alpha spirometer.

chevron_right View Article

Contact Us